Literature DB >> 11454801

Overexpression of the CD155 gene in human colorectal carcinoma.

D Masson1, A Jarry, B Baury, P Blanchardie, C Laboisse, P Lustenberger, M G Denis.   

Abstract

BACKGROUND AND AIMS: The Tage4 gene (tumour associated glycoprotein E4) is overexpressed in rat colon tumours and Min mouse intestinal adenomas. The rat Tage4 protein has approximately 40% identity with human CD155, a member of the immunoglobulin superfamily coding for a transmembrane protein capable of serving as an entry receptor for poliovirus, porcine pseudorabies virus, and bovine herpesvirus 1. Analysis of the rat Tage4 gene has revealed structural and functional similarities with the human CD155 gene. We therefore investigated expression of the CD155 gene in human colorectal carcinomas.
METHODS: Overall CD155 expression was assessed by semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemical analysis using tissue specimens from patients with colorectal adenomas and adenocarcinomas. We also used a qualitative RT-PCR assay to determine relative expression of different splicing variants in each sample.
RESULTS: mRNA levels of CD155 were increased in six of six colorectal cancer tissues compared with the tumour free colon mucosa. Immunohistochemical analysis revealed an increased level of CD155 protein in 12 of 12 samples. The qualitative RT-PCR assay revealed that relative expression of the different CD155 variant transcripts was similar in the different normal and cancer samples tested, indicating that this overexpression is not associated with a particular mRNA variant generated by alternative splicing of the CD155 gene.
CONCLUSION: We have shown for the first time that the CD155 gene is overexpressed in colorectal carcinoma and that this overexpression begins at an early stage in tumorigenesis and continues to late stages.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454801      PMCID: PMC1728395          DOI: 10.1136/gut.49.2.236

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  29 in total

Review 1.  Viral receptors of the immunoglobulin superfamily.

Authors:  J M White; D R Littman
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

2.  Production of a monoclonal antibody against an epitope on HeLa cells that is the functional poliovirus binding site.

Authors:  P Nobis; R Zibirre; G Meyer; J Kühne; G Warnecke; G Koch
Journal:  J Gen Virol       Date:  1985-12       Impact factor: 3.891

3.  Monoclonal antibodies to a rat colon carcinoma: model for monoclonal antibody therapy of solid tumors.

Authors:  J Y Douillard; J Laborda; C Burg; J Ridge; I Levenbook; H Blottière; B Sela; T Hoffman; S Ben Ami
Journal:  Cancer Res       Date:  1989-02-01       Impact factor: 12.701

4.  Nectin-3, a new member of immunoglobulin-like cell adhesion molecules that shows homophilic and heterophilic cell-cell adhesion activities.

Authors:  K Satoh-Horikawa; H Nakanishi; K Takahashi; M Miyahara; M Nishimura; K Tachibana; A Mizoguchi; Y Takai
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

Review 5.  The immunoglobulin superfamily--domains for cell surface recognition.

Authors:  A F Williams; A N Barclay
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

6.  Organization of the rat Tage4 gene and herpesvirus entry activity of the encoded protein.

Authors:  B Baury; R J Geraghty; D Masson; P Lustenberger; P G Spear; M G Denis
Journal:  Gene       Date:  2001-03-07       Impact factor: 3.688

7.  Interleukin 1 and interleukin 1beta converting enzyme (caspase 1) expression in the human colonic epithelial barrier. Caspase 1 downregulation in colon cancer.

Authors:  A Jarry; G Vallette; E Cassagnau; A Moreau; C Bou-Hanna; P Lemarre; E Letessier; J C Le Neel; J P Galmiche; C L Laboisse
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

8.  The major human rhinovirus receptor is ICAM-1.

Authors:  J M Greve; G Davis; A M Meyer; C P Forte; S C Yost; C W Marlor; M E Kamarck; A McClelland
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

9.  A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses.

Authors:  D E Staunton; V J Merluzzi; R Rothlein; R Barton; S D Marlin; T A Springer
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

10.  De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis.

Authors:  J P Johnson; B G Stade; B Holzmann; W Schwäble; G Riethmüller
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

View more
  88 in total

1.  Intranodal interaction with dendritic cells dynamically regulates surface expression of the co-stimulatory receptor CD226 protein on murine T cells.

Authors:  Sebastian Seth; Quan Qiu; Simon Danisch; Michael K Maier; Asolina Braun; Inga Ravens; Niklas Czeloth; Rebecca Hyde; Oliver Dittrich-Breiholz; Reinhold Förster; Günter Bernhardt
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

Review 2.  A novel interface consisting of homologous immunoglobulin superfamily members with multiple functions.

Authors:  Zhuwei Xu; Boquan Jin
Journal:  Cell Mol Immunol       Date:  2010-01       Impact factor: 11.530

3.  The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity.

Authors:  Noa Stanietsky; Hrvoje Simic; Jurica Arapovic; Amir Toporik; Ofer Levy; Amit Novik; Zurit Levine; Meirav Beiman; Liat Dassa; Hagit Achdout; Noam Stern-Ginossar; Pinhas Tsukerman; Stipan Jonjic; Ofer Mandelboim
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

Review 4.  Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme.

Authors:  Christian Goetz; Matthias Gromeier
Journal:  Cytokine Growth Factor Rev       Date:  2010-03-17       Impact factor: 7.638

5.  Interaction of nectin-like molecule 2 with integrin alpha6beta4 and inhibition of disassembly of integrin alpha6beta4 from hemidesmosomes.

Authors:  Kiyohito Mizutani; Satoshi Kawano; Akihiro Minami; Masazumi Waseda; Wataru Ikeda; Yoshimi Takai
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

6.  Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2.

Authors:  Satoshi Kawano; Wataru Ikeda; Megumi Kishimoto; Hisakazu Ogita; Yoshimi Takai
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

7.  Overexpression of CD155 relates to metastasis and invasion in osteosarcoma.

Authors:  Baobiao Zhuo; Yuan Li; Feng Gu; Zhengwei Li; Qingzeng Sun; Yingchun Shi; Yang Shen; Fengfei Zhang; Rong Wang; Xiaodong Wang
Journal:  Oncol Lett       Date:  2018-03-09       Impact factor: 2.967

Review 8.  Targeting PVR (CD155) and its receptors in anti-tumor therapy.

Authors:  Paola Kučan Brlić; Tihana Lenac Roviš; Guy Cinamon; Pini Tsukerman; Ofer Mandelboim; Stipan Jonjić
Journal:  Cell Mol Immunol       Date:  2018-10-01       Impact factor: 11.530

Review 9.  Oncolytic polio virotherapy of cancer.

Authors:  Michael C Brown; Elena Y Dobrikova; Mikhail I Dobrikov; Ross W Walton; Sarah L Gemberling; Smita K Nair; Annick Desjardins; John H Sampson; Henry S Friedman; Allan H Friedman; Douglas S Tyler; Darell D Bigner; Matthias Gromeier
Journal:  Cancer       Date:  2014-06-17       Impact factor: 6.860

Review 10.  Heart failure in cancer: role of checkpoint inhibitors.

Authors:  Murilo Delgobo; Stefan Frantz
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.